4+ day, 8+ hour ago   (211+ words) The Clinical Trial Vanguard Senn Framework Targets Protocol-Specific Content for Live Site Initiation Visits Generic GCP slides do not cause protocol deviations. Misunderstood eligibility criteria and missed pharmacokinetic sampling windows do. That distinction is the entire argument of Christine Senn’s…...

4+ day, 8+ hour ago   (386+ words) The Clinical Trial Vanguard Seismic Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Istaroxime for Cardiogenic Shock Cardiogenic shock kills roughly half the patients it reaches in the ICU, a mortality burden that has persisted for decades without a single…...

5+ day, 7+ hour ago   (463+ words) clinicaltrialvanguard.com Advarra Releases IRB Reportable Events Checklist to Reduce Over-Reporting Most research teams think the hard part of IRB compliance is catching every event. The harder part, the one that actually generates audit findings, is knowing which events to…...

6+ day, 2+ hour ago   (903+ words) The Clinical Trial Vanguard AI in Clinical Trials Doesn’t Have a Capability Problem. It Has a Honesty Problem. Mohanish Anand, TA Head for Global Trial Management, ran a simple test: he asked ChatGPT, Claude, Gemini, Perplexity, DeepSeek, and Copilot to…...

1+ week, 8+ hour ago   (442+ words) The Clinical Trial Vanguard Clover’s RSV-hMPV Vaccine Shows Antibody Rises in Phase 2 Trial More than half of American adults 75 and older have already received one of the approved RSV vaccines, which creates an awkward problem for any late-entrant vaccine: the…...

1+ week, 1+ day ago   (383+ words) The Clinical Trial Vanguard FDA Guidance Expands Cancer Trial Eligibility, Reshaping Feasibility Models Forty percent of Phase III cancer trials explicitly barred patients with an ECOG performance status of 2 or higher, and among trials that allowed those patients, they made…...

1+ week, 2+ day ago   (423+ words) The Clinical Trial Vanguard AI Agents in Clinical Trials Require Human Review Before Data Commits A phase 3 protocol in 2020 collected an average of 3.56 million data points. By 2025 that number had climbed to 5.96 million, a 67% rise in five years and more…...

1+ week, 4+ day ago   (486+ words) The Clinical Trial Vanguard WCG releases checklist to speed protocol amendment implementation at clinical trial sites Three-point-three amendments per protocol, on average, across trials that get amended at all, and 76% of trials now require at least one, up from 57% in…...

1+ week, 4+ day ago   (198+ words) That failure carries weight far beyond the TNBC space. Every immuno-oncology sponsor running a Phase 3 program with a PD-L1 inhibitor, in any indication, should be reading the B-59 readout and asking a harder question than “did it work?” The harder question…...

1+ week, 6+ day ago   (745+ words) The Clinical Trial Vanguard Stop Writing ‘Routine Labs.’ Every Lab Line Needs Its Own Coverage Citation A billing compliance officer at a mid-sized academic medical center once pulled a coverage analysis for a Phase II oncology trial and found a single…...